These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5303363)

  • 21. [Hormonal therapy of cancer of the breast, current ideas].
    BONARD EC
    Praxis; 1958 Jun; 47(23):561-2. PubMed ID: 13567320
    [No Abstract]   [Full Text] [Related]  

  • 22. Medicinal drugs with hormonal activity as chemopreventive agents.
    Cuzick J
    IARC Sci Publ; 1996; (139):99-114. PubMed ID: 8923022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hormonal prevention of recurrence of breast carcinoma].
    Ehlers PN
    Wien Klin Wochenschr; 1970 Jun; 82(26):478-81. PubMed ID: 5520163
    [No Abstract]   [Full Text] [Related]  

  • 24. [Endocrinological aspects of fibrocystic mastopathy].
    Angelia A; Dogliotti L; Borretta G; Violino PL
    Recenti Prog Med; 1982 Jan; 72(1):31-64. PubMed ID: 7043677
    [No Abstract]   [Full Text] [Related]  

  • 25. A comprehensive review of the safety and efficacy of bioidentical hormones for the management of menopause and related health risks.
    Moskowitz D
    Altern Med Rev; 2006 Sep; 11(3):208-23. PubMed ID: 17217322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Directed hormone therapy of malignant tumors of the breast].
    Vepkhvadze KF; Mardakhiashvili ShI; Pavlov KA
    Vestn Khir Im I I Grek; 1968 May; 100(5):18-21. PubMed ID: 5660824
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hormonal therapy of the climateric syndrome (preliminary report].
    Morales Lepe C; Eguiluz Lopez B
    Ginecol Obstet Mex; 1967 Jul; 22(129):891-900. PubMed ID: 5604289
    [No Abstract]   [Full Text] [Related]  

  • 28. Association of new-onset breast discomfort with an increase in mammographic density during hormone therapy.
    Crandall CJ; Karlamangla A; Huang MH; Ursin G; Guan M; Greendale GA
    Arch Intern Med; 2006 Aug 14-28; 166(15):1578-84. PubMed ID: 16908790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen replacement therapy and benign breast disease.
    Trapido EJ; Brinton LA; Schairer C; Hoover R
    J Natl Cancer Inst; 1984 Nov; 73(5):1101-5. PubMed ID: 6092767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Behavior of hormonal patterns in breast neoplasms. Physiopathologic and clinical considerations].
    Giordano G; Cacciari P
    Arch Sci Med (Torino); 1968 Oct; 125(10):525-35. PubMed ID: 5735716
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of tibolone and oestrogen-based HT on breast cell proliferation and mammographic density.
    von Schoultz B
    Maturitas; 2004 Sep; 49(1):S16-21. PubMed ID: 15351103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study finds taking estrogen alone doesn't increase breast cancer risk.
    Mayo Clin Womens Healthsource; 2006 Sep; 10(9):3. PubMed ID: 16909091
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of hormone replacement therapy on mammographic findings.
    Bülbül NH; Ozden S; Dayicioglu V
    Arch Gynecol Obstet; 2003 Apr; 268(1):5-8. PubMed ID: 12673467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [On the hormonal treatment of metastatic mammary carcinoma].
    Pickert H
    Ther Ggw; 1965 Oct; 104(10):1327-37. PubMed ID: 5879858
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of tibolone and conventional HRT on the expression of estrogen and progesterone receptors in the breast.
    Ma L; Hofling M; Masironi B; von Schoultz B; Cline JM; Sahlin L
    Maturitas; 2008 Dec; 61(4):345-9. PubMed ID: 18980817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel inhibitor of breast cell growth that is down-regulated by estrogens and decreased in breast tumors.
    Wittmann BM; Wang N; Montano MM
    Cancer Res; 2003 Aug; 63(16):5151-8. PubMed ID: 12941847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Conservative hormonal treatment of metastatic mammary cancer].
    Doorenbos H
    Neurochirurgie; 1966 Nov; 12(6):703-4. PubMed ID: 5972235
    [No Abstract]   [Full Text] [Related]  

  • 38. Estrogenic microenvironment generated by organochlorine residues in adipose mammary tissue modulates biomarker expression in ERalpha-positive breast carcinomas.
    Muñoz-de-Toro M; Durando M; Beldoménico PM; Beldoménico HR; Kass L; García SR; Luque EH
    Breast Cancer Res; 2006; 8(4):R47. PubMed ID: 16859517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Endocrine therapy for breast cancer. Round table discussion].
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1413-26. PubMed ID: 8346942
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of black cohosh on estrogen biosynthesis in normal breast tissue in vitro.
    Stute P; Nisslein T; Götte M; Kamischke A; Kiesel L; Klockenbusch W
    Maturitas; 2007 Aug; 57(4):382-91. PubMed ID: 17548177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.